Atrás
Precio Affymax Inc (AFFY)
Gráfico del Precio de Acciones AFFY
AFFY Ganando
Affymax Inc
$0
0%
$0
Al cierre: Jan 16, 16:00:00 GMT-5
$0
0%
$0
Mercado Posterior: Jan 16, 20:00:00 GMT-5
Estadísticas clave
Cierre Anterior
$0.0008
Precio de apertura
$0.0009
Rango del día
$0.0008 - $0.0009
Rango de 52 semanas
$0.0001 - $0.003
Volumen
6.0K
Volumen promedio
16.1K
EPS (TTM)
0.07
Rendimiento de dividendos
--
Cap. de mercado
$29.9K
¿Qué es AFFY?
Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
